Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001968719 | SCV002255811 | likely pathogenic | Neurofibromatosis, type 1 | 2024-12-18 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 36 of the NF1 gene. It does not directly change the encoded amino acid sequence of the NF1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with neurofibromatosis, type 1 (PMID: 27322474, 37186028). ClinVar contains an entry for this variant (Variation ID: 1467882). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV003471211 | SCV004190807 | likely pathogenic | Juvenile myelomonocytic leukemia | 2022-05-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004719213 | SCV005325653 | likely pathogenic | not provided | 2023-09-08 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect: patient-derived cDNA demonstrated two aberrant transcripts both leading to a frameshift and premature truncation (Evans et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27322474) |